SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '9CR'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A52_A_ESTA1_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 1a52A-1xlsA:23.8 | 1a52A-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A52_B_ESTB2_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.02A | 1a52B-1xlsA:23.7 | 1a52B-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AX9_A_EDRA999_1 (ACETYLCHOLINESTERASE) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 4 / 8 | GLY A 315PHE A 412PHE A 413HIS A 409 | NoneNoneNone9CR A 201 (-4.8A) | 0.93A | 1ax9A-1xiuA:undetectable | 1ax9A-1xiuA:16.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AX9_A_EDRA999_1 (ACETYLCHOLINESTERASE) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 8 | GLY A 341PHE A 438PHE A 439HIS A 435 | NoneNoneNone9CR A7223 (-4.3A) | 1.00A | 1ax9A-3dzuA:undetectable | 1ax9A-3dzuA:22.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_A_ESTA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 9 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 1ereA-1xlsA:25.6 | 1ereA-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_B_ESTB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 9 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 1ereB-1xlsA:25.6 | 1ereB-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_C_ESTC600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 9 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 1ereC-1xlsA:25.5 | 1ereC-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_D_ESTD600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 9 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 1ereD-1xlsA:25.6 | 1ereD-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_E_ESTE600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 4 / 8 | ALA A 246LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.90A | 1ereE-1xiuA:23.4 | 1ereE-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_E_ESTE600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 8 | ALA A 272LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.89A | 1ereE-1xlsA:25.6 | 1ereE-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_E_ESTE600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 8 | ALA A 272LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.86A | 1ereE-3dzuA:25.4 | 1ereE-3dzuA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_F_ESTF600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 4 / 8 | ALA A 246LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.91A | 1ereF-1xiuA:23.4 | 1ereF-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERE_F_ESTF600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 8 | ALA A 272LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.91A | 1ereF-1xlsA:25.5 | 1ereF-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_F_ESTF600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 8 | ALA A 272LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.87A | 1ereF-3dzuA:25.4 | 1ereF-3dzuA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 250TRP A 279ARG A 290ILE A 402 | 9CR A 201 (-3.6A)NoneNone9CR A 201 (-2.8A)None | 1.07A | 1errA-1xiuA:22.2 | 1errA-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ERR_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 428 | 9CR A 801 (-3.5A)NoneNone9CR A 801 (-2.6A)None | 1.17A | 1errA-1xlsA:22.1 | 1errA-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 428 | 9CR A7223 (-4.2A)NoneNone9CR A7223 (-3.7A)None | 1.03A | 1errA-3dzuA:21.9 | 1errA-3dzuA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_A_RALA600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 428 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.0A)None | 1.24A | 1errA-5uanA:21.7 | 1errA-5uanA:24.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_B_RALB600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ILE A 428 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)None | 0.87A | 1errB-3dzuA:22.1 | 1errB-3dzuA:20.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242CYH A 243ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406HIS A 409 | 9CR A 201 ( 4.4A)9CR A 201 ( 3.8A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 (-4.8A) | 0.33A | 1fbyA-1xiuA:31.8 | 1fbyA-1xiuA:80.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A 801 (-3.9A)9CR A 801 ( 4.5A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None | 0.41A | 1fbyA-1xlsA:33.7 | 1fbyA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A7223 (-3.9A)None9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 (-4.3A) | 0.71A | 1fbyA-3dzuA:33.1 | 1fbyA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.60A | 1fbyA-5uanA:33.3 | 1fbyA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A 503 (-4.0A)9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None | 0.52A | 1fbyA-5uanA:33.3 | 1fbyA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_B_9CRB1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242CYH A 243ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406HIS A 409 | 9CR A 201 ( 4.4A)9CR A 201 ( 3.8A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 (-4.8A) | 0.31A | 1fbyB-1xiuA:31.3 | 1fbyB-1xiuA:80.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_B_9CRB1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A 801 (-3.9A)9CR A 801 ( 4.5A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None | 0.39A | 1fbyB-1xlsA:32.9 | 1fbyB-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_B_9CRB1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A7223 (-3.9A)None9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 (-4.3A) | 0.72A | 1fbyB-3dzuA:32.4 | 1fbyB-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_B_9CRB1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.60A | 1fbyB-5uanA:32.4 | 1fbyB-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FBY_B_9CRB1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435 | 9CR A 503 (-4.0A)9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None | 0.51A | 1fbyB-5uanA:32.4 | 1fbyB-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.36A | 1fm6A-1xiuA:31.9 | 1fm6A-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.32A | 1fm6A-1xlsA:36.8 | 1fm6A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.67A | 1fm6A-3dzuA:32.4 | 1fm6A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.57A | 1fm6A-5uanA:33.0 | 1fm6A-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ALA A 245ALA A 246PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316ILE A 319CYH A 406HIS A 409LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.33A | 1fm6U-1xiuA:31.7 | 1fm6U-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | TRP A 279VAL A 316ILE A 319CYH A 406HIS A 409LEU A 410 | None9CR A 201 (-4.2A)None9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.96A | 1fm6U-1xiuA:31.7 | 1fm6U-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.39A | 1fm6U-1xlsA:36.7 | 1fm6U-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | TRP A 305VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | None9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 1.11A | 1fm6U-1xlsA:36.7 | 1fm6U-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428CYH A 432LEU A 436 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)None9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 1.47A | 1fm6U-3dzuA:32.6 | 1fm6U-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.62A | 1fm6U-3dzuA:32.6 | 1fm6U-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | TRP A 305VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | None9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 1.13A | 1fm6U-3dzuA:32.6 | 1fm6U-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.24A | 1fm6U-5uanA:33.0 | 1fm6U-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)NoneNone9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.55A | 1fm6U-5uanA:33.0 | 1fm6U-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_U_9CRU502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | TRP A 305VAL A 342ILE A 345CYH A 432HIS A 435LEU A 436 | NoneNoneNone9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 1.16A | 1fm6U-5uanA:33.0 | 1fm6U-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.31A | 1fm9A-1xiuA:32.4 | 1fm9A-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.32A | 1fm9A-1xlsA:37.5 | 1fm9A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.62A | 1fm9A-3dzuA:32.7 | 1fm9A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 1fm9A-5uanA:33.1 | 1fm9A-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 3 / 3 | GLN A 249ILE A 319HIS A 409 | 9CR A 201 (-4.1A)None9CR A 201 (-4.8A) | 0.33A | 1fm9A-1xiuA:32.4 | 1fm9A-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 801 (-4.7A)9CR A 801 ( 4.5A)None | 0.40A | 1fm9A-1xlsA:37.5 | 1fm9A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A7223 (-4.6A)9CR A7223 ( 4.9A)9CR A7223 (-4.3A) | 0.52A | 1fm9A-3dzuA:32.7 | 1fm9A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM9_A_9CRA201_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 503 (-3.8A)NoneNone | 0.39A | 1fm9A-5uanA:33.1 | 1fm9A-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | TRP A 279LEU A 283ARG A 290LEU A 300ALA A 301 | None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A) | 0.55A | 1g5yB-1xiuA:27.4 | 1g5yB-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | TRP A 305LEU A 309ARG A 316LEU A 326ALA A 327 | None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A) | 0.49A | 1g5yB-1xlsA:27.5 | 1g5yB-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | TRP A 305LEU A 309ARG A 316LEU A 326ALA A 327 | None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.56A | 1g5yB-3dzuA:25.5 | 1g5yB-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_C_9CRC502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 10 | LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301 | 9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A) | 0.59A | 1g5yC-1xiuA:27.6 | 1g5yC-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_C_9CRC502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 10 | LEU A 309SER A 312PHE A 313ARG A 316LEU A 326ALA A 327 | 9CR A 801 (-4.2A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A) | 0.54A | 1g5yC-1xlsA:27.5 | 1g5yC-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_C_9CRC502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 10 | LEU A 309SER A 312PHE A 313ARG A 316LEU A 326ALA A 327 | 9CR A7223 ( 4.4A)9CR A7223 ( 4.0A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.87A | 1g5yC-3dzuA:25.5 | 1g5yC-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G5Y_C_9CRC502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 10 | LEU A 309SER A 312PHE A 313ARG A 316LEU A 326ALA A 327 | 9CR A 503 (-3.7A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A) | 0.53A | 1g5yC-5uanA:25.5 | 1g5yC-5uanA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HWI_B_115B1_1 (HMG-COA REDUCTASE) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 9 | CYH A 432LEU A 451ALA A 272LEU A 276LEU A 309 | 9CR A 801 ( 3.7A)None9CR A 801 (-3.5A)None9CR A 801 (-4.2A) | 1.25A | 1hwiA-1xlsA:undetectable | 1hwiA-1xlsA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1J7K_A_ACTA701_0 (HOLLIDAY JUNCTIONDNA HELICASE RUVB) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 4 / 4 | GLY B 294LEU B 391GLY B 296ARG B 387 | 9CR B 600 (-4.7A)NoneNoneNone | 1.27A | 1j7kA-1xdkB:undetectable | 1j7kA-1xdkB:22.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.31A | 1k74A-1xiuA:32.2 | 1k74A-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.36A | 1k74A-1xlsA:37.4 | 1k74A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.64A | 1k74A-3dzuA:32.8 | 1k74A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.56A | 1k74A-5uanA:33.2 | 1k74A-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 3 / 3 | GLN A 249ILE A 319HIS A 409 | 9CR A 201 (-4.1A)None9CR A 201 (-4.8A) | 0.33A | 1k74A-1xiuA:32.2 | 1k74A-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 801 (-4.7A)9CR A 801 ( 4.5A)None | 0.34A | 1k74A-1xlsA:37.4 | 1k74A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A7223 (-4.6A)9CR A7223 ( 4.9A)9CR A7223 (-4.3A) | 0.47A | 1k74A-3dzuA:32.8 | 1k74A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1K74_A_9CRA463_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 503 (-3.8A)NoneNone | 0.40A | 1k74A-5uanA:33.2 | 1k74A-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PCG_A_ESTA1_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.99A | 1pcgA-1xlsA:25.5 | 1pcgA-1xlsA:32.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 283ARG A 290ILE A 319ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNoneNone | 1.03A | 1qknA-1xiuA:23.1 | 1qknA-1xiuA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 309ARG A 316ILE A 345ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)NoneNone | 1.03A | 1qknA-1xlsA:22.4 | 1qknA-1xlsA:31.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.9A)9CR A7223 ( 4.7A) | 0.98A | 1qknA-3dzuA:22.6 | 1qknA-3dzuA:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)NoneNone | 0.94A | 1qknA-3dzuA:22.6 | 1qknA-3dzuA:20.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QKU_A_ESTA600_1 (ESTRADIOL RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.98A | 1qkuA-1xlsA:25.4 | 1qkuA-1xlsA:31.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QKU_B_ESTB600_1 (ESTRADIOL RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.98A | 1qkuB-1xlsA:25.5 | 1qkuB-1xlsA:31.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1QKU_C_ESTC600_1 (ESTRADIOL RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.98A | 1qkuC-1xlsA:25.5 | 1qkuC-1xlsA:31.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245GLN A 249TRP A 279ASN A 280PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)NoneNone9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.46A | 1xdkA-1xiuA:31.6 | 1xdkA-1xiuA:81.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)NoneNone9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.40A | 1xdkA-1xlsA:34.9 | 1xdkA-1xlsA:99.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316LEU A 326VAL A 342LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.6A)None9CR A7223 (-3.9A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.5A)9CR A7223 ( 4.7A) | 0.76A | 1xdkA-3dzuA:33.7 | 1xdkA-3dzuA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.70A | 1xdkA-3dzuA:33.7 | 1xdkA-3dzuA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)NoneNone9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.56A | 1xdkA-5uanA:34.4 | 1xdkA-5uanA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_E_9CRE1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.45A | 1xdkE-1xiuA:31.6 | 1xdkE-1xiuA:81.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_E_9CRE1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.40A | 1xdkE-1xlsA:34.9 | 1xdkE-1xlsA:99.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_E_9CRE1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.67A | 1xdkE-3dzuA:33.7 | 1xdkE-3dzuA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XDK_E_9CRE1500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.55A | 1xdkE-5uanA:34.4 | 1xdkE-5uanA:99.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_A_9CRA201_1 (RXR-LIKE PROTEIN) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 ( 4.5A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.37A | 1xiuA-1xlsA:31.6 | 1xiuA-1xlsA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_A_9CRA201_1 (RXR-LIKE PROTEIN) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)None9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.67A | 1xiuA-3dzuA:30.3 | 1xiuA-3dzuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_A_9CRA201_1 (RXR-LIKE PROTEIN) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268CYH A 269ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.50A | 1xiuA-5uanA:30.3 | 1xiuA-5uanA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.35A | 1xiuB-1xlsA:35.4 | 1xiuB-1xlsA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.58A | 1xiuB-3dzuA:33.1 | 1xiuB-3dzuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.58A | 1xiuB-5uanA:33.9 | 1xiuB-5uanA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_A_9CRA801_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.38A | 1xlsA-1xiuA:31.6 | 1xlsA-1xiuA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_A_9CRA801_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.64A | 1xlsA-3dzuA:32.9 | 1xlsA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_A_9CRA801_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 1xlsA-5uanA:33.1 | 1xlsA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_B_9CRB802_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.38A | 1xlsB-1xiuA:31.7 | 1xlsB-1xiuA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_B_9CRB802_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.64A | 1xlsB-3dzuA:32.9 | 1xlsB-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_B_9CRB802_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 1xlsB-5uanA:33.2 | 1xlsB-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_C_9CRC803_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.38A | 1xlsC-1xiuA:31.6 | 1xlsC-1xiuA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_C_9CRC803_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.64A | 1xlsC-3dzuA:32.9 | 1xlsC-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_C_9CRC803_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 1xlsC-5uanA:33.2 | 1xlsC-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_D_9CRD804_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.38A | 1xlsD-1xiuA:31.6 | 1xlsD-1xiuA:82.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_D_9CRD804_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.64A | 1xlsD-3dzuA:32.9 | 1xlsD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLS_D_9CRD804_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 1xlsD-5uanA:33.2 | 1xlsD-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ALA A 245ALA A 246GLN A 249ASN A 280LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 0.49A | 2aclA-1xiuA:30.62aclE-1xiuA:30.6 | 2aclA-1xiuA:81.092aclE-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.47A | 2aclA-1xlsA:29.82aclE-1xlsA:29.6 | 2aclA-1xlsA:100.002aclE-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316LEU A 326ILE A 345CYH A 432 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-3.9A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.75A | 2aclA-3dzuA:29.92aclE-3dzuA:29.9 | 2aclA-3dzuA:100.002aclE-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 12 | GLN A 275LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.73A | 2aclA-3dzuA:29.92aclE-3dzuA:29.9 | 2aclA-3dzuA:100.002aclE-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.63A | 2aclA-5uanA:29.72aclE-5uanA:29.6 | 2aclA-5uanA:100.002aclE-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_A_REAA502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.31A | 2aclA-5uanA:29.72aclE-5uanA:29.6 | 2aclA-5uanA:100.002aclE-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 10 | ILE A 242ALA A 245ALA A 246GLN A 249ASN A 280PHE A 287ARG A 290ALA A 301ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 0.40A | 2aclC-1xiuA:30.9 | 2aclC-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.45A | 2aclC-1xlsA:29.8 | 2aclC-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 10 | ALA A 271ALA A 272GLN A 275ASN A 306PHE A 313ARG A 316ILE A 345CYH A 432 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-3.9A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.77A | 2aclC-3dzuA:30.1 | 2aclC-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.81A | 2aclC-3dzuA:30.1 | 2aclC-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 10 | ALA A 271ALA A 272PHE A 313ARG A 316ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None | 1.38A | 2aclC-5uanA:29.8 | 2aclC-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_C_REAC503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.62A | 2aclC-5uanA:29.8 | 2aclC-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 11 | ILE A 242ALA A 245ALA A 246GLN A 249ASN A 280LEU A 283PHE A 287ARG A 290ALA A 301ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 0.51A | 2aclE-1xiuA:30.6 | 2aclE-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.58A | 2aclE-1xlsA:29.6 | 2aclE-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 11 | ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316ILE A 345CYH A 432 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-3.9A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.84A | 2aclE-3dzuA:29.9 | 2aclE-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.87A | 2aclE-3dzuA:29.9 | 2aclE-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 271ALA A 272ASN A 306LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.69A | 2aclE-5uanA:29.6 | 2aclE-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_E_REAE504_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None | 0.65A | 2aclE-5uanA:29.6 | 2aclE-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 12 | ALA A 245ALA A 246GLN A 249ASN A 280LEU A 283ILE A 284PHE A 287ARG A 290ALA A 301CYH A 406 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 ( 4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)9CR A 201 (-3.6A) | 0.78A | 2aclG-1xiuA:29.7 | 2aclG-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249LEU A 283ILE A 284PHE A 287ARG A 290LEU A 300ALA A 301CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-3.6A) | 0.57A | 2aclG-1xiuA:29.7 | 2aclG-1xiuA:81.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.2A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 3.7A) | 0.78A | 2aclG-1xlsA:28.7 | 2aclG-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-3.9A)9CR A7223 ( 4.4A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 (-3.8A) | 0.86A | 2aclG-3dzuA:29.0 | 2aclG-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272ASN A 306LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)9CR A 503 (-3.3A) | 0.87A | 2aclG-5uanA:28.7 | 2aclG-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ACL_G_REAG501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ASN A 306LEU A 309ILE A 310PHE A 313LEU A 326ALA A 327 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-3.7A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-4.3A)9CR A 503 (-3.4A) | 0.68A | 2aclG-5uanA:28.7 | 2aclG-5uanA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J0D_A_ERYA1498_0 (CYTOCHROME P450 3A4) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ARG A 371ILE A 428ILE A 345PHE A 346ALA A 272 | NoneNone9CR A 801 ( 4.5A)None9CR A 801 (-3.5A) | 1.04A | 2j0dA-1xlsA:undetectable | 2j0dA-1xlsA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J0D_A_ERYA1498_0 (CYTOCHROME P450 3A4) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ARG A 371ILE A 428ILE A 345PHE A 346ALA A 272 | NoneNoneNoneNone9CR A 503 (-3.5A) | 1.17A | 2j0dA-5uanA:undetectable | 2j0dA-5uanA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ARG A 290ILE A 402 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 1.04A | 2jfaA-1xiuA:23.3 | 2jfaA-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ILE A 319 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)None | 1.02A | 2jfaA-1xiuA:23.3 | 2jfaA-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.83A | 2jfaA-1xiuA:23.3 | 2jfaA-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ILE A 319LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)None9CR A 201 ( 4.8A) | 0.89A | 2jfaA-1xiuA:23.3 | 2jfaA-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 345 | 9CR A 801 (-3.5A)NoneNone9CR A 801 (-2.6A)9CR A 801 ( 4.5A) | 0.99A | 2jfaA-1xlsA:22.6 | 2jfaA-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.91A | 2jfaA-1xlsA:22.6 | 2jfaA-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.86A | 2jfaA-1xlsA:22.6 | 2jfaA-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ILE A 345LEU A 436 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.9A)9CR A7223 ( 4.7A) | 0.85A | 2jfaA-3dzuA:22.7 | 2jfaA-3dzuA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)None | 1.02A | 2jfaA-3dzuA:22.7 | 2jfaA-3dzuA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.87A | 2jfaA-3dzuA:22.7 | 2jfaA-3dzuA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.7A)9CR A 503 (-3.0A)None | 1.20A | 2jfaA-5uanA:22.4 | 2jfaA-5uanA:23.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-3.0A)9CR A 503 ( 4.8A) | 1.03A | 2jfaA-5uanA:22.4 | 2jfaA-5uanA:23.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246ASP A 247LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 1.09A | 2jfaB-1xiuA:22.9 | 2jfaB-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ARG A 290GLY A 403 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 0.89A | 2jfaB-1xiuA:22.9 | 2jfaB-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.82A | 2jfaB-1xiuA:22.9 | 2jfaB-1xiuA:27.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316GLY A 429 | 9CR A 801 (-3.5A)NoneNone9CR A 801 (-2.6A)None | 0.97A | 2jfaB-1xlsA:22.6 | 2jfaB-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)None | 0.95A | 2jfaB-1xlsA:22.6 | 2jfaB-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.85A | 2jfaB-1xlsA:22.6 | 2jfaB-1xlsA:26.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)None | 0.88A | 2jfaB-3dzuA:22.3 | 2jfaB-3dzuA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.87A | 2jfaB-3dzuA:22.3 | 2jfaB-3dzuA:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.7A)9CR A 503 (-3.0A)None | 1.05A | 2jfaB-5uanA:9.8 | 2jfaB-5uanA:23.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-3.0A)9CR A 503 ( 4.8A) | 1.03A | 2jfaB-5uanA:9.8 | 2jfaB-5uanA:23.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2LBD_A_REAA500_1 (RETINOIC ACIDRECEPTOR GAMMA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 10 / 12 | PHE B 221CYH B 228LEU B 262ARG B 265ILE B 266ARG B 269PHE B 279SER B 280GLY B 384LEU B 391 | 9CR B 600 ( 4.7A)9CR B 600 (-3.4A)9CR B 600 (-3.9A)None9CR B 600 ( 3.8A)9CR B 600 (-3.8A)9CR B 600 (-4.5A)9CR B 600 (-3.0A)9CR B 600 ( 4.6A)None | 0.55A | 2lbdA-1xdkB:37.7 | 2lbdA-1xdkB:79.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2LBD_A_REAA500_1 (RETINOIC ACIDRECEPTOR GAMMA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 6 / 12 | PHE B 221LYS B 227LEU B 262PHE B 279GLY B 384LEU B 391 | 9CR B 600 ( 4.7A)None9CR B 600 (-3.9A)9CR B 600 (-4.5A)9CR B 600 ( 4.6A)None | 1.07A | 2lbdA-1xdkB:37.7 | 2lbdA-1xdkB:79.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ARG A 290ILE A 319 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 1.13A | 2qxsA-1xiuA:22.9 | 2qxsA-1xiuA:29.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ARG A 290ILE A 402 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 1.07A | 2qxsA-1xiuA:22.9 | 2qxsA-1xiuA:29.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290ILE A 319LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None9CR A 201 ( 4.8A) | 1.00A | 2qxsA-1xiuA:22.9 | 2qxsA-1xiuA:29.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 345 | 9CR A 801 (-3.5A)NoneNone9CR A 801 (-2.6A)9CR A 801 ( 4.5A) | 1.02A | 2qxsA-1xlsA:23.0 | 2qxsA-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.95A | 2qxsA-1xlsA:23.0 | 2qxsA-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)None | 1.09A | 2qxsA-1xlsA:23.0 | 2qxsA-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)None | 0.99A | 2qxsA-3dzuA:22.9 | 2qxsA-3dzuA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.80A | 2qxsA-3dzuA:22.9 | 2qxsA-3dzuA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.7A)9CR A 503 (-3.0A)None | 1.20A | 2qxsA-5uanA:22.3 | 2qxsA-5uanA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ARG A 290ILE A 402 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 1.07A | 2qxsB-1xiuA:22.8 | 2qxsB-1xiuA:29.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 250TRP A 279LEU A 283ILE A 319 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)None | 1.06A | 2qxsB-1xiuA:22.8 | 2qxsB-1xiuA:29.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.94A | 2qxsB-1xiuA:22.8 | 2qxsB-1xiuA:29.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 276TRP A 305ARG A 316ILE A 345 | 9CR A 801 (-3.5A)NoneNone9CR A 801 (-2.6A)9CR A 801 ( 4.5A) | 1.03A | 2qxsB-1xlsA:22.5 | 2qxsB-1xlsA:31.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.98A | 2qxsB-1xlsA:22.5 | 2qxsB-1xlsA:31.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)None | 1.01A | 2qxsB-3dzuA:22.8 | 2qxsB-3dzuA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.83A | 2qxsB-3dzuA:22.8 | 2qxsB-3dzuA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_B_RALB600_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.7A)9CR A 503 (-3.0A)None | 1.21A | 2qxsB-5uanA:22.3 | 2qxsB-5uanA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.99A | 2yjaB-1xiuA:23.1 | 2yjaB-1xiuA:29.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.03A | 2yjaB-1xlsA:25.9 | 2yjaB-1xlsA:31.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 1.05A | 2yjaB-1xlsA:25.9 | 2yjaB-1xlsA:31.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A9E_B_REAB1_1 (RETINOIC ACIDRECEPTOR ALPHA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 5 / 11 | ILE B 266ARG B 269PHE B 279SER B 280LEU B 213 | 9CR B 600 ( 3.8A)9CR B 600 (-3.8A)9CR B 600 (-4.5A)9CR B 600 (-3.0A)None | 1.35A | 3a9eB-1xdkB:37.9 | 3a9eB-1xdkB:77.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3A9E_B_REAB1_1 (RETINOIC ACIDRECEPTOR ALPHA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 10 / 11 | PHE B 221CYH B 228LEU B 262ILE B 266ARG B 269PHE B 279SER B 280PHE B 295VAL B 388LEU B 391 | 9CR B 600 ( 4.7A)9CR B 600 (-3.4A)9CR B 600 (-3.9A)9CR B 600 ( 3.8A)9CR B 600 (-3.8A)9CR B 600 (-4.5A)9CR B 600 (-3.0A)9CR B 600 (-3.9A)9CR B 600 ( 4.6A)None | 0.42A | 3a9eB-1xdkB:37.9 | 3a9eB-1xdkB:77.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 12 | ALA A 245GLN A 249ASN A 280ILE A 284PHE A 287ARG A 290LEU A 300VAL A 316HIS A 409LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 (-4.1A)NoneNone9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-4.2A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.69A | 3dzuA-1xiuA:30.3 | 3dzuA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ILE A 242ALA A 245GLN A 249ILE A 284PHE A 287ARG A 290LEU A 300VAL A 316CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.53A | 3dzuA-1xiuA:30.3 | 3dzuA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271GLN A 275ASN A 306ILE A 310PHE A 313ARG A 316LEU A 326VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.6A)9CR A 801 (-4.7A)NoneNone9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.64A | 3dzuA-1xlsA:32.9 | 3dzuA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.51A | 3dzuA-1xlsA:32.9 | 3dzuA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271GLN A 275ASN A 306ILE A 310PHE A 313ARG A 316LEU A 326VAL A 342CYH A 432 | 9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)None9CR A 503 (-3.3A) | 0.84A | 3dzuA-5uanA:32.9 | 3dzuA-5uanA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZU_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)None9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.71A | 3dzuA-5uanA:32.9 | 3dzuA-5uanA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ILE A 242ALA A 245GLN A 249ASN A 280PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.65A | 3dzyA-1xiuA:29.1 | 3dzyA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 271GLN A 275ASN A 306ARG A 316ALA A 327LEU A 455 | 9CR A 801 (-3.6A)9CR A 801 (-4.7A)None9CR A 801 (-2.6A)9CR A 801 (-3.3A)None | 1.31A | 3dzyA-1xlsA:31.0 | 3dzyA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271GLN A 275ASN A 306PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.66A | 3dzyA-1xlsA:31.0 | 3dzyA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271GLN A 275ASN A 306SER A 312PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.6A)9CR A7223 (-3.9A)9CR A7223 ( 4.0A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.67A | 3dzyA-3dzuA:34.1 | 3dzyA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ILE A 268ALA A 272SER A 312PHE A 313VAL A 342 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 ( 4.0A)9CR A7223 (-4.5A)9CR A7223 ( 4.5A) | 1.13A | 3dzyA-3dzuA:34.1 | 3dzyA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_A_9CRA463_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271GLN A 275ASN A 306SER A 312PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)NoneNone9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.84A | 3dzyA-5uanA:31.8 | 3dzyA-5uanA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279ASN A 280PHE A 287ARG A 290ALA A 301VAL A 316ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)NoneNone9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A) | 0.47A | 3e00A-1xiuA:31.1 | 3e00A-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)NoneNone9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.42A | 3e00A-1xlsA:33.3 | 3e00A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ILE A 268ALA A 271GLN A 275PHE A 313VAL A 342ILE A 345 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A) | 1.37A | 3e00A-1xlsA:33.3 | 3e00A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316VAL A 342ILE A 345 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-3.9A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A) | 0.74A | 3e00A-3dzuA:34.6 | 3e00A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A) | 0.60A | 3e00A-3dzuA:34.6 | 3e00A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316VAL A 342ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.51A | 3e00A-3dzuA:34.6 | 3e00A-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None | 1.32A | 3e00A-5uanA:33.5 | 3e00A-5uanA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305ASN A 306PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)NoneNone9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)NoneNone9CR A 503 (-3.3A) | 0.56A | 3e00A-5uanA:33.5 | 3e00A-5uanA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 10 | ILE A 242ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290ALA A 301VAL A 316ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A) | 0.41A | 3falA-1xiuA:30.1 | 3falA-1xiuA:81.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.37A | 3falA-1xlsA:29.3 | 3falA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.78A | 3falA-3dzuA:29.5 | 3falA-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 10 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None | 1.40A | 3falA-5uanA:28.7 | 3falA-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)NoneNone9CR A 503 (-3.3A) | 0.64A | 3falA-5uanA:28.7 | 3falA-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 10 | ILE A 242ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 0.36A | 3falC-1xiuA:30.1 | 3falC-1xiuA:81.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.32A | 3falC-1xlsA:29.4 | 3falC-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.79A | 3falC-3dzuA:29.8 | 3falC-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 10 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.37A | 3falC-5uanA:29.1 | 3falC-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 10 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.59A | 3falC-5uanA:29.1 | 3falC-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 11 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 0.40A | 3fc6A-1xiuA:30.7 | 3fc6A-1xiuA:81.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.42A | 3fc6A-1xlsA:30.0 | 3fc6A-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.72A | 3fc6A-3dzuA:30.5 | 3fc6A-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 11 | ILE A 268ALA A 271GLN A 275PHE A 313ARG A 316ALA A 327ILE A 345 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A) | 1.50A | 3fc6A-3dzuA:30.5 | 3fc6A-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 11 | ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.26A | 3fc6A-5uanA:29.9 | 3fc6A-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.58A | 3fc6A-5uanA:29.9 | 3fc6A-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | VAL A 239CYH A 243ALA A 245ALA A 246GLN A 249LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406 | 9CR A 201 ( 4.8A)9CR A 201 ( 3.8A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A) | 0.35A | 3fc6C-1xiuA:31.3 | 3fc6C-1xiuA:81.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | VAL A 265ALA A 271GLN A 275PHE A 313ARG A 316VAL A 342 | 9CR A 801 ( 4.6A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 ( 4.3A) | 1.50A | 3fc6C-1xlsA:30.5 | 3fc6C-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | VAL A 265CYH A 269ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432 | 9CR A 801 ( 4.6A)9CR A 801 ( 4.5A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A) | 0.38A | 3fc6C-1xlsA:30.5 | 3fc6C-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | VAL A 265CYH A 269ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432 | 9CR A7223 ( 4.5A)None9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A) | 0.71A | 3fc6C-3dzuA:30.3 | 3fc6C-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FC6_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | VAL A 265CYH A 269ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432 | None9CR A 503 ( 4.4A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.58A | 3fc6C-5uanA:30.0 | 3fc6C-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 245ALA A 246GLN A 249TRP A 279ARG A 290ILE A 402 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-2.8A)None | 1.28A | 3h0aA-1xiuA:29.4 | 3h0aA-1xiuA:82.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 12 | ALA A 245ALA A 246GLN A 249TRP A 279LEU A 283ARG A 290LEU A 300VAL A 316ILE A 319LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-4.2A)None9CR A 201 ( 4.8A) | 0.69A | 3h0aA-1xiuA:29.4 | 3h0aA-1xiuA:82.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 8 / 12 | ALA A 245ALA A 246LEU A 283ARG A 290LEU A 300VAL A 316ILE A 319CYH A 406 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A) | 0.75A | 3h0aA-1xiuA:29.4 | 3h0aA-1xiuA:82.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 9 / 12 | ALA A 245GLN A 249LEU A 283ARG A 290LEU A 300ALA A 301VAL A 316ILE A 319LEU A 410 | 9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 ( 4.8A) | 0.71A | 3h0aA-1xiuA:29.4 | 3h0aA-1xiuA:82.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271ALA A 272GLN A 275ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)None | 1.30A | 3h0aA-1xlsA:31.5 | 3h0aA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305LEU A 309ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345LEU A 436 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.71A | 3h0aA-1xlsA:31.5 | 3h0aA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271ALA A 272LEU A 309ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.81A | 3h0aA-1xlsA:31.5 | 3h0aA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 271GLN A 275ARG A 316ALA A 327VAL A 342ILE A 345 | 9CR A 801 (-3.6A)9CR A 801 (-4.7A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A) | 1.44A | 3h0aA-1xlsA:31.5 | 3h0aA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305LEU A 309ARG A 316LEU A 326LEU A 436 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.78A | 3h0aA-3dzuA:31.5 | 3h0aA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271ALA A 272TRP A 305LEU A 309ARG A 316LEU A 326VAL A 342ILE A 345LEU A 436 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 ( 4.7A) | 0.74A | 3h0aA-3dzuA:31.5 | 3h0aA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 271GLN A 275TRP A 305ARG A 316LEU A 326ILE A 428 | 9CR A7223 (-3.5A)9CR A7223 (-4.6A)None9CR A7223 (-3.7A)9CR A7223 (-3.8A)None | 1.35A | 3h0aA-3dzuA:31.5 | 3h0aA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271LEU A 309ARG A 316LEU A 326VAL A 342ILE A 345CYH A 432 | 9CR A7223 (-3.5A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.93A | 3h0aA-3dzuA:31.5 | 3h0aA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305LEU A 309ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432LEU A 436 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-3.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)NoneNone9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.70A | 3h0aA-5uanA:31.7 | 3h0aA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 3 / 3 | ILE A 242PHE A 287HIS A 409 | 9CR A 201 ( 4.4A)9CR A 201 (-4.7A)9CR A 201 (-4.8A) | 0.55A | 3h0aA-1xiuA:29.4 | 3h0aA-1xiuA:82.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | ILE A 268PHE A 313HIS A 435 | 9CR A 801 (-3.9A)9CR A 801 (-4.3A)None | 0.54A | 3h0aA-1xlsA:31.5 | 3h0aA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H0A_A_9RAA500_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | ILE A 268PHE A 313HIS A 435 | 9CR A7223 (-3.9A)9CR A7223 (-4.5A)9CR A7223 (-4.3A) | 0.66A | 3h0aA-3dzuA:31.5 | 3h0aA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LBD_A_9CRA424_1 (RETINOIC ACIDRECEPTOR GAMMA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 10 / 12 | PHE B 221ALA B 225LEU B 259LEU B 262ILE B 266ARG B 269SER B 280PHE B 295GLY B 384ILE B 403 | 9CR B 600 ( 4.7A)9CR B 600 (-3.8A)None9CR B 600 (-3.9A)9CR B 600 ( 3.8A)9CR B 600 (-3.8A)9CR B 600 (-3.0A)9CR B 600 (-3.9A)9CR B 600 ( 4.6A)9CR B 600 ( 4.4A) | 0.55A | 3lbdA-1xdkB:37.5 | 3lbdA-1xdkB:79.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OAP_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316ILE A 319CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.27A | 3oapA-1xiuA:33.1 | 3oapA-1xiuA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OAP_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ILE A 242ALA A 246GLN A 249PHE A 287VAL A 316ILE A 319 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-4.2A)None | 1.43A | 3oapA-1xiuA:33.1 | 3oapA-1xiuA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OAP_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.34A | 3oapA-1xlsA:35.6 | 3oapA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OAP_A_9CRA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342ILE A 345CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.62A | 3oapA-3dzuA:33.9 | 3oapA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OLS_B_ESTB600_1 (ESTROGEN RECEPTORBETA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.04A | 3olsB-1xlsA:25.2 | 3olsB-1xlsA:30.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.94A | 3q95A-1xiuA:23.0 | 3q95A-1xiuA:28.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 1.00A | 3q95A-1xlsA:26.0 | 3q95A-1xlsA:30.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)NoneNone | 0.99A | 3q95A-3dzuA:25.5 | 3q95A-3dzuA:20.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 503 (-3.5A)9CR A 503 (-3.7A)9CR A 503 (-3.0A)NoneNone | 1.07A | 3q95A-5uanA:25.5 | 3q95A-5uanA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.97A | 3q95B-1xiuA:22.7 | 3q95B-1xiuA:28.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 1.04A | 3q95B-1xlsA:25.4 | 3q95B-1xlsA:30.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A7223 (-4.2A)9CR A7223 ( 4.4A)9CR A7223 (-3.7A)NoneNone | 1.01A | 3q95B-3dzuA:25.0 | 3q95B-3dzuA:20.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_B_ESLB700_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 503 (-3.5A)9CR A 503 (-3.7A)9CR A 503 (-3.0A)NoneNone | 1.09A | 3q95B-5uanA:24.9 | 3q95B-5uanA:24.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249LEU A 283PHE A 287ARG A 290ALA A 301VAL A 316ILE A 319CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)None9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.36A | 3uvvB-1xiuA:32.4 | 3uvvB-1xiuA:81.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.43A | 3uvvB-1xlsA:36.0 | 3uvvB-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A) | 0.47A | 3uvvB-1xlsA:36.0 | 3uvvB-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ILE A 268ALA A 271GLN A 275PHE A 313VAL A 342ILE A 345 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 ( 4.3A)9CR A 801 ( 4.5A) | 1.47A | 3uvvB-1xlsA:36.0 | 3uvvB-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316VAL A 342ILE A 345CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.55A | 3uvvB-3dzuA:34.1 | 3uvvB-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A) | 0.62A | 3uvvB-3dzuA:34.1 | 3uvvB-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ILE A 268ALA A 272PHE A 313VAL A 342ILE A 345 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 (-4.5A)9CR A7223 ( 4.5A)9CR A7223 ( 4.9A) | 1.25A | 3uvvB-3dzuA:34.1 | 3uvvB-3dzuA:51.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 271ALA A 272PHE A 313ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.4A)None | 1.23A | 3uvvB-5uanA:34.4 | 3uvvB-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)NoneNone9CR A 503 ( 4.8A) | 0.55A | 3uvvB-5uanA:34.4 | 3uvvB-5uanA:66.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UVV_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327VAL A 342ILE A 345CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)NoneNone9CR A 503 (-3.3A) | 0.70A | 3uvvB-5uanA:34.4 | 3uvvB-5uanA:66.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AC9_C_DXCC1476_0 (MJ0495-LIKE PROTEIN) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 4 / 5 | ILE A 242ALA A 245HIS A 305ARG A 290 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)None9CR A 201 (-2.8A) | 1.17A | 4ac9B-1xiuA:undetectable4ac9C-1xiuA:undetectable | 4ac9B-1xiuA:21.844ac9C-1xiuA:21.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DM8_A_REAA501_1 (RETINOIC ACIDRECEPTOR BETA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 11 / 11 | PHE B 221CYH B 228LEU B 259LEU B 262ILE B 263ARG B 269PHE B 279SER B 280LEU B 298LEU B 391ILE B 403 | 9CR B 600 ( 4.7A)9CR B 600 (-3.4A)None9CR B 600 (-3.9A)9CR B 600 (-4.0A)9CR B 600 (-3.8A)9CR B 600 (-4.5A)9CR B 600 (-3.0A)9CR B 600 (-4.7A)None9CR B 600 ( 4.4A) | 0.50A | 4dm8A-1xdkB:37.7 | 4dm8A-1xdkB:92.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DM8_B_REAB1501_1 (RETINOIC ACIDRECEPTOR BETA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 12 / 12 | PHE B 192PHE B 221LEU B 224ALA B 225LEU B 259LEU B 262ILE B 263ARG B 269SER B 280PHE B 295GLY B 384LEU B 391 | 9CR B 600 (-4.8A)9CR B 600 ( 4.7A)9CR B 600 ( 4.0A)9CR B 600 (-3.8A)None9CR B 600 (-3.9A)9CR B 600 (-4.0A)9CR B 600 (-3.8A)9CR B 600 (-3.0A)9CR B 600 (-3.9A)9CR B 600 ( 4.6A)None | 0.51A | 4dm8B-1xdkB:38.2 | 4dm8B-1xdkB:92.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249LEU A 283ILE A 284PHE A 287ARG A 290LEU A 300ALA A 301VAL A 323 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None | 0.33A | 4k6iA-1xiuA:32.7 | 4k6iA-1xiuA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 8 / 12 | ILE A 242ALA A 245GLN A 249ILE A 284PHE A 287ARG A 290LEU A 300CYH A 406 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.6A) | 0.68A | 4k6iA-1xiuA:32.7 | 4k6iA-1xiuA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | LEU A 283ILE A 284PHE A 287ALA A 245VAL A 323 | 9CR A 201 ( 4.1A)None9CR A 201 (-4.7A)9CR A 201 (-3.6A)None | 1.02A | 4k6iA-1xiuA:32.7 | 4k6iA-1xiuA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327VAL A 349 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)None | 0.37A | 4k6iA-1xlsA:35.3 | 4k6iA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-4.2A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 3.7A) | 0.69A | 4k6iA-1xlsA:35.3 | 4k6iA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | LEU A 309ILE A 310PHE A 313ALA A 271VAL A 349 | 9CR A 801 (-4.2A)None9CR A 801 (-4.3A)9CR A 801 (-3.6A)None | 1.06A | 4k6iA-1xlsA:35.3 | 4k6iA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 271ALA A 272GLN A 275LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326VAL A 349 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)None | 0.51A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 12 | GLN A 275LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327VAL A 349 | 9CR A7223 (-4.6A)9CR A7223 ( 4.4A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)None | 0.63A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309ILE A 310PHE A 313ARG A 316VAL A 349 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)None | 0.54A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ILE A 268ILE A 310PHE A 313ARG A 316CYH A 432 | 9CR A7223 (-3.9A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A) | 1.01A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ILE A 310PHE A 313ARG A 316LEU A 326CYH A 432 | None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 (-3.8A) | 0.95A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | LEU A 309ILE A 310PHE A 313ALA A 271VAL A 349 | 9CR A7223 ( 4.4A)None9CR A7223 (-4.5A)9CR A7223 (-3.5A)None | 1.10A | 4k6iA-3dzuA:33.7 | 4k6iA-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K6I_A_9RAA500_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327VAL A 349CYH A 432 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A) | 0.52A | 4k6iA-5uanA:34.4 | 4k6iA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 11 | ILE A 242ALA A 245GLN A 249PHE A 287VAL A 316HIS A 409 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-4.2A)9CR A 201 (-4.8A) | 1.49A | 4nqaA-1xiuA:32.0 | 4nqaA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 11 | ILE A 242ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.55A | 4nqaA-1xiuA:32.0 | 4nqaA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 11 | ILE A 242ALA A 246GLN A 249PHE A 287LEU A 300ALA A 301VAL A 316CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.39A | 4nqaA-1xiuA:32.0 | 4nqaA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.53A | 4nqaA-1xlsA:34.0 | 4nqaA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 272GLN A 275PHE A 313LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.37A | 4nqaA-1xlsA:34.0 | 4nqaA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.76A | 4nqaA-3dzuA:32.2 | 4nqaA-3dzuA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 11 | ILE A 268ALA A 272GLN A 275PHE A 313LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.74A | 4nqaA-3dzuA:32.2 | 4nqaA-3dzuA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.57A | 4nqaA-5uanA:33.2 | 4nqaA-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 12 | ILE A 242ALA A 245ALA A 246ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.51A | 4nqaH-1xiuA:31.1 | 4nqaH-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.48A | 4nqaH-1xiuA:31.1 | 4nqaH-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.50A | 4nqaH-1xlsA:34.1 | 4nqaH-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ILE A 268ALA A 272ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.5A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.54A | 4nqaH-1xlsA:34.1 | 4nqaH-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.66A | 4nqaH-3dzuA:32.4 | 4nqaH-3dzuA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.73A | 4nqaH-3dzuA:32.4 | 4nqaH-3dzuA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.72A | 4nqaH-5uanA:33.3 | 4nqaH-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)9CR A 503 ( 4.8A) | 0.62A | 4nqaH-5uanA:33.3 | 4nqaH-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313LEU A 326ALA A 327HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 ( 4.8A) | 0.46A | 4nqaH-5uanA:33.3 | 4nqaH-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.64A | 4nqaH-5uanA:33.3 | 4nqaH-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NQA_H_9CRH501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ILE A 268ALA A 271ALA A 272PHE A 313LEU A 326ALA A 327CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-4.7A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.50A | 4nqaH-5uanA:33.3 | 4nqaH-5uanA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 11 | ALA A 246LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.97A | 4pxmB-1xiuA:23.3 | 4pxmB-1xiuA:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 11 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.02A | 4pxmB-1xlsA:25.5 | 4pxmB-1xlsA:29.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 11 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 1.04A | 4pxmB-1xlsA:25.5 | 4pxmB-1xlsA:29.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 11 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 503 (-3.5A)9CR A 503 (-3.7A)9CR A 503 (-3.0A)NoneNone | 1.10A | 4pxmB-5uanA:25.5 | 4pxmB-5uanA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WNV_D_QI9D602_0 (CYTOCHROME P450 2D6) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 4 / 7 | PHE A 439LEU A 436VAL A 265PHE A 346 | None9CR A 503 ( 4.8A)NoneNone | 1.04A | 4wnvD-5uanA:undetectable | 4wnvD-5uanA:22.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_A_29SA601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246ASP A 247LEU A 250TRP A 279ARG A 290 | 9CR A 201 (-3.6A)NoneNoneNone9CR A 201 (-2.8A) | 1.31A | 4xi3A-1xiuA:22.5 | 4xi3A-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_A_29SA601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246ASP A 247TRP A 279ARG A 290LEU A 410 | 9CR A 201 (-3.6A)NoneNone9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 1.12A | 4xi3A-1xiuA:22.5 | 4xi3A-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_A_29SA601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272ASP A 273LEU A 276TRP A 305ARG A 316 | 9CR A7223 (-4.2A)NoneNoneNone9CR A7223 (-3.7A) | 1.30A | 4xi3A-3dzuA:22.8 | 4xi3A-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_A_29SA601_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272ASP A 273TRP A 305ARG A 316LEU A 436 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.0A)9CR A 503 ( 4.8A) | 1.25A | 4xi3A-5uanA:22.3 | 4xi3A-5uanA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246ASP A 247TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)NoneNone9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 1.08A | 4xi3B-1xiuA:22.4 | 4xi3B-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246LEU A 250TRP A 279ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)NoneNone9CR A 201 (-2.8A)NoneNone | 1.08A | 4xi3B-1xiuA:22.4 | 4xi3B-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 6 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.95A | 4xi3B-1xiuA:22.4 | 4xi3B-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 0.99A | 4xi3B-1xlsA:22.8 | 4xi3B-1xlsA:31.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)None | 0.91A | 4xi3B-1xlsA:22.8 | 4xi3B-1xlsA:31.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.92A | 4xi3B-1xlsA:22.8 | 4xi3B-1xlsA:31.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ILE A 345LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 0.86A | 4xi3B-1xlsA:22.8 | 4xi3B-1xlsA:31.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272ASP A 273LEU A 276TRP A 305LEU A 309ARG A 316 | 9CR A7223 (-4.2A)NoneNoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A) | 1.25A | 4xi3B-3dzuA:22.7 | 4xi3B-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272ASP A 273TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 1.04A | 4xi3B-3dzuA:22.7 | 4xi3B-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)NoneNone | 1.03A | 4xi3B-3dzuA:22.7 | 4xi3B-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272ASP A 273TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 503 (-3.5A)NoneNone9CR A 503 (-3.7A)9CR A 503 (-3.0A)9CR A 503 ( 4.8A) | 1.21A | 4xi3B-5uanA:22.3 | 4xi3B-5uanA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-3.0A)NoneNone | 1.10A | 4xi3B-5uanA:22.3 | 4xi3B-5uanA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246LEU A 250TRP A 279ARG A 290GLY A 403 | 9CR A 201 (-3.6A)NoneNone9CR A 201 (-2.8A)None | 0.96A | 4xi3C-1xiuA:22.3 | 4xi3C-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290GLY A 403 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)None | 0.80A | 4xi3C-1xiuA:22.3 | 4xi3C-1xiuA:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.96A | 4xi3C-1xiuA:22.3 | 4xi3C-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)None | 0.91A | 4xi3C-1xlsA:22.2 | 4xi3C-1xlsA:31.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.92A | 4xi3C-1xlsA:22.2 | 4xi3C-1xlsA:31.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 272LEU A 276TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A7223 (-4.2A)NoneNone9CR A7223 ( 4.4A)9CR A7223 (-3.7A)None | 0.92A | 4xi3C-3dzuA:22.5 | 4xi3C-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.85A | 4xi3C-3dzuA:22.5 | 4xi3C-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316GLY A 429 | 9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-3.0A)None | 0.99A | 4xi3C-5uanA:21.8 | 4xi3C-5uanA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_D_29SD601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 12 | ALA A 246TRP A 279LEU A 283ARG A 290LEU A 410 | 9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-2.8A)9CR A 201 ( 4.8A) | 0.97A | 4xi3D-1xiuA:22.6 | 4xi3D-1xiuA:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_D_29SD601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 (-4.7A) | 0.91A | 4xi3D-1xlsA:22.4 | 4xi3D-1xlsA:31.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_D_29SD601_1 (ESTROGEN RECEPTOR) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 12 | ALA A 272TRP A 305LEU A 309ARG A 316LEU A 436 | 9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A) | 0.85A | 4xi3D-3dzuA:22.9 | 4xi3D-3dzuA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXB_B_ESTB601_1 (ESTROGEN RECEPTOR) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 5 / 11 | ALA A 246LEU A 283ARG A 290ILE A 402GLY A 403 | 9CR A 201 (-3.6A)9CR A 201 ( 4.1A)9CR A 201 (-2.8A)NoneNone | 0.98A | 5dxbB-1xiuA:23.2 | 5dxbB-1xiuA:28.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXB_B_ESTB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 11 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.02A | 5dxbB-1xlsA:25.6 | 5dxbB-1xlsA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXB_B_ESTB601_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 11 | ALA A 272LEU A 309ARG A 316ILE A 428GLY A 429 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)NoneNone | 1.03A | 5dxbB-1xlsA:25.6 | 5dxbB-1xlsA:29.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 11 / 11 | ILE A 242GLN A 249TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-4.1A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.32A | 5ji0A-1xiuA:32.7 | 5ji0A-1xiuA:79.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268GLN A 275TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-4.7A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.34A | 5ji0A-1xlsA:34.7 | 5ji0A-1xlsA:99.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268GLN A 275TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-4.6A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.62A | 5ji0A-3dzuA:33.8 | 5ji0A-3dzuA:59.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_A_9CRA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 11 | ILE A 268GLN A 275TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.8A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.64A | 5ji0A-5uanA:32.7 | 5ji0A-5uanA:91.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M24_A_9CRA501_1 (RETINOIC ACIDRECEPTOR GAMMA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 11 / 12 | TRP B 218PHE B 221ALA B 225LEU B 262ILE B 266ARG B 269SER B 280PHE B 295GLY B 384LEU B 391ILE B 403 | None9CR B 600 ( 4.7A)9CR B 600 (-3.8A)9CR B 600 (-3.9A)9CR B 600 ( 3.8A)9CR B 600 (-3.8A)9CR B 600 (-3.0A)9CR B 600 (-3.9A)9CR B 600 ( 4.6A)None9CR B 600 ( 4.4A) | 0.49A | 5m24A-1xdkB:37.5 | 5m24A-1xdkB:79.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UAN_A_9CRA503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.51A | 5uanA-1xiuA:30.3 | 5uanA-1xiuA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UAN_A_9CRA503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.52A | 5uanA-1xlsA:33.1 | 5uanA-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UAN_A_9CRA503_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.81A | 5uanA-3dzuA:32.9 | 5uanA-3dzuA:78.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UAN_B_REAB503_1 (RETINOIC ACIDRECEPTOR BETA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 12 / 12 | PHE B 221ALA B 225CYH B 228LEU B 259LEU B 262ILE B 263ILE B 266PHE B 279SER B 280PHE B 295LEU B 298VAL B 388 | 9CR B 600 ( 4.7A)9CR B 600 (-3.8A)9CR B 600 (-3.4A)None9CR B 600 (-3.9A)9CR B 600 (-4.0A)9CR B 600 ( 3.8A)9CR B 600 (-4.5A)9CR B 600 (-3.0A)9CR B 600 (-3.9A)9CR B 600 (-4.7A)9CR B 600 ( 4.6A) | 0.43A | 5uanB-1xdkB:38.3 | 5uanB-1xdkB:98.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UAN_B_REAB503_1 (RETINOIC ACIDRECEPTOR BETA) |
1xdk | RETINOIC ACIDRECEPTOR, BETA (Musmusculus) | 5 / 12 | PHE B 221CYH B 228LEU B 407PHE B 279PHE B 295 | 9CR B 600 ( 4.7A)9CR B 600 (-3.4A)None9CR B 600 (-4.5A)9CR B 600 (-3.9A) | 1.33A | 5uanB-1xdkB:38.3 | 5uanB-1xdkB:98.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246TRP A 279LEU A 283PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)None9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.36A | 5z12B-1xiuA:32.8 | 5z12B-1xiuA:73.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)None9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.33A | 5z12B-1xlsA:35.4 | 5z12B-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)None9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.60A | 5z12B-3dzuA:33.8 | 5z12B-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272TRP A 305LEU A 309PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)None9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.53A | 5z12B-5uanA:34.4 | 5z12B-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 3 / 3 | GLN A 249ILE A 319HIS A 409 | 9CR A 201 (-4.1A)None9CR A 201 (-4.8A) | 0.39A | 5z12B-1xiuA:32.8 | 5z12B-1xiuA:73.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 801 (-4.7A)9CR A 801 ( 4.5A)None | 0.49A | 5z12B-1xlsA:35.4 | 5z12B-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A7223 (-4.6A)9CR A7223 ( 4.9A)9CR A7223 (-4.3A) | 0.38A | 5z12B-3dzuA:33.8 | 5z12B-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_B_9CRB501_2 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | GLN A 275ILE A 345HIS A 435 | 9CR A 503 (-3.8A)NoneNone | 0.43A | 5z12B-5uanA:34.4 | 5z12B-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_C_9CRC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301VAL A 316CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)9CR A 201 (-4.2A)9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.47A | 5z12C-1xiuA:30.6 | 5z12C-1xiuA:73.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_C_9CRC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.3A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.42A | 5z12C-1xlsA:33.0 | 5z12C-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_C_9CRC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.5A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.70A | 5z12C-3dzuA:33.0 | 5z12C-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Z12_C_9CRC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327VAL A 342CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.68A | 5z12C-5uanA:33.3 | 5z12C-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 10 / 12 | ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301ILE A 402CYH A 406 | 9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A) | 1.48A | 6a5yD-1xiuA:32.3 | 6a5yD-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249TRP A 279PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.45A | 6a5yD-1xiuA:32.3 | 6a5yD-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 6 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305ALA A 327LEU A 455 | 9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-3.3A)None | 1.32A | 6a5yD-1xlsA:34.9 | 6a5yD-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.40A | 6a5yD-1xlsA:34.9 | 6a5yD-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428CYH A 432 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)None9CR A7223 (-3.8A) | 1.45A | 6a5yD-3dzuA:34.1 | 6a5yD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.68A | 6a5yD-3dzuA:34.1 | 6a5yD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 12 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.34A | 6a5yD-5uanA:34.7 | 6a5yD-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275TRP A 305PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)None9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.60A | 6a5yD-5uanA:34.7 | 6a5yD-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 3 / 3 | ASN A 280VAL A 316HIS A 409 | None9CR A 201 (-4.2A)9CR A 201 (-4.8A) | 0.33A | 6a5yD-1xiuA:32.3 | 6a5yD-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Y_D_9CRD501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 3 / 3 | ASN A 306VAL A 342HIS A 435 | None9CR A 801 ( 4.3A)None | 0.24A | 6a5yD-1xlsA:34.9 | 6a5yD-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249ILE A 284PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)None9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A)9CR A 201 ( 4.8A) | 0.39A | 6a5zD-1xiuA:33.0 | 6a5zD-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)None9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)9CR A 801 (-4.7A) | 0.31A | 6a5zD-1xlsA:35.4 | 6a5zD-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ALA A 271ALA A 272GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326ILE A 345CYH A 432LEU A 436 | 9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.53A | 6a5zD-3dzuA:34.2 | 6a5zD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 9 / 12 | ALA A 272GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432LEU A 436 | 9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.55A | 6a5zD-3dzuA:34.2 | 6a5zD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ILE A 310PHE A 313ARG A 316ILE A 345CYH A 432LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)None9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A) | 0.50A | 6a5zD-3dzuA:34.2 | 6a5zD-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 ( 4.8A) | 0.45A | 6a5zD-5uanA:34.6 | 6a5zD-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 10 / 12 | ILE A 268ALA A 271ALA A 272ILE A 310PHE A 313ARG A 316LEU A 326ALA A 327CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 ( 4.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.52A | 6a5zD-5uanA:34.6 | 6a5zD-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_L_9CRL501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249PHE A 287ARG A 290LEU A 300ALA A 301ILE A 319CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-4.4A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.40A | 6a5zL-1xiuA:32.3 | 6a5zL-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_L_9CRL501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-4.1A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.34A | 6a5zL-1xlsA:34.7 | 6a5zL-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_L_9CRL501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 (-3.8A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.68A | 6a5zL-3dzuA:34.0 | 6a5zL-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_L_9CRL501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 8 / 12 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None | 1.40A | 6a5zL-5uanA:34.4 | 6a5zL-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A5Z_L_9CRL501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316LEU A 326ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-4.3A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.58A | 6a5zL-5uanA:34.4 | 6a5zL-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xiu | RXR-LIKE PROTEIN (Biomphalariaglabrata) | 12 / 12 | ILE A 242ALA A 245ALA A 246GLN A 249LEU A 283PHE A 287ARG A 290ALA A 301ILE A 319CYH A 406HIS A 409LEU A 410 | 9CR A 201 ( 4.4A)9CR A 201 (-3.6A)9CR A 201 (-3.6A)9CR A 201 (-4.1A)9CR A 201 ( 4.1A)9CR A 201 (-4.7A)9CR A 201 (-2.8A)9CR A 201 (-3.4A)None9CR A 201 (-3.6A)9CR A 201 (-4.8A)9CR A 201 ( 4.8A) | 0.35A | 6a60D-1xiuA:32.3 | 6a60D-1xiuA:75.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 801 (-3.9A)9CR A 801 (-3.6A)9CR A 801 (-3.5A)9CR A 801 (-4.7A)9CR A 801 (-4.2A)9CR A 801 (-4.3A)9CR A 801 (-2.6A)9CR A 801 (-3.3A)9CR A 801 ( 4.5A)9CR A 801 ( 3.7A)None9CR A 801 (-4.7A) | 0.40A | 6a60D-1xlsA:35.0 | 6a60D-1xlsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
3dzu | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 12 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A7223 (-3.9A)9CR A7223 (-3.5A)9CR A7223 (-4.2A)9CR A7223 (-4.6A)9CR A7223 ( 4.4A)9CR A7223 (-4.5A)9CR A7223 (-3.7A)9CR A7223 ( 4.7A)9CR A7223 ( 4.9A)9CR A7223 (-3.8A)9CR A7223 (-4.3A)9CR A7223 ( 4.7A) | 0.62A | 6a60D-3dzuA:34.4 | 6a60D-3dzuA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 7 / 12 | ALA A 271ALA A 272GLN A 275PHE A 313ARG A 316ALA A 327ILE A 428 | 9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None | 1.46A | 6a60D-5uanA:34.5 | 6a60D-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ALA A 327ILE A 345CYH A 432HIS A 435LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)None9CR A 503 ( 4.8A) | 0.59A | 6a60D-5uanA:34.5 | 6a60D-5uanA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A60_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5uan | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 11 / 12 | ILE A 268ALA A 271ALA A 272GLN A 275LEU A 309PHE A 313ARG A 316ALA A 327ILE A 345CYH A 432LEU A 436 | 9CR A 503 (-4.0A)9CR A 503 (-3.5A)9CR A 503 (-3.5A)9CR A 503 (-3.8A)9CR A 503 (-3.7A)9CR A 503 (-4.7A)9CR A 503 (-3.0A)9CR A 503 (-3.4A)None9CR A 503 (-3.3A)9CR A 503 ( 4.8A) | 0.69A | 6a60D-5uanA:34.5 | 6a60D-5uanA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CBZ_B_ESTB602_1 (ESTROGEN RECEPTOR) |
1xls | RETINOIC ACIDRECEPTOR RXR-ALPHA (Homosapiens) | 5 / 10 | ALA A 272LEU A 309ARG A 316ILE A 345LEU A 436 | 9CR A 801 (-3.5A)9CR A 801 (-4.2A)9CR A 801 (-2.6A)9CR A 801 ( 4.5A)9CR A 801 (-4.7A) | 1.04A | 6cbzB-1xlsA:25.6 | 6cbzB-1xlsA:18.92 |